WHO ICTRP trial
Open, randomized, controlled, multicenter phase II study comparing 5-FU/FA plus…
EUCTR2005-000970-37-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000970-37-DE |
|---|---|
| Public title | Open, randomized, controlled, multicenter phase II study comparing 5-FU/FA plus oxaliplatin (FOLFOX 4) plus cetuximab versus 5-FU/FA plus oxaliplatin as first-line treatment for epidermal growth factor receptor-expressing metastatic colorectal cancer - OPUS |
| Scientific title | Open, randomized, controlled, multicenter phase II study comparing 5-FU/FA plus oxaliplatin (FOLFOX 4) plus cetuximab versus 5-FU/FA plus oxaliplatin as first-line treatment for epidermal growth factor receptor-expressing metastatic colorectal cancer - OPUS |
| Primary sponsor | Merck KGaA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal;Germany;Spain;Italy |
| Conditions | Metastatic colon rectal carcinoma MedDRA version: 7.0 Level: LLT Classification code 10052362 |
| Interventions | Product Name: Erbitux Product Code: EMD271786 Pharmaceutical Form: Solution for infusion INN or Proposed INN: Cetuximab Current Sponsor code: EMD271786 Other descriptive name: Cetuximab Concentration unit: mg/ml milligram(s)/millilitre… |
| Registration date | Jun 23, 2005 |
| Target size | 300 |
| Secondary IDs | EMR62202-047 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: